Choosing Wisely in endometrial & cervix cancers: Surgery

Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable advanced melanoma

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

No benefit for adjuvant durvalumab in completely resected NSCLC

ESMO 2024: Highlights and analysis

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer

Total neoadjuvant treatment without surgery for locally advanced rectal cancer

ESMO 2024: Latest in bladder cancer - expert review

Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectable NPNSCC

Bladder cancer updates from the first half of 2024

ASCO 2024: Highlights and analysis

Transoral surgery and neck dissection with deintensified risk-based post-operative management increases efficacy in oropharynx cancer